FindTrial
Sign In

To compare two adjuvent magnesium sulphate and dexmeditomidine with bupivacaine in spinal anasthesia

A study to compare the efficacy of intrathecal dexmedetomidine and magnesium sulphate as an adjuvent to 0.5% hyperbaric bupivacaine in patients undergoing various infra umbilical surgeries under spinal anasthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017796
Enrollment
120
Registered
2019-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Spinal anasthesia: For onset time of motor and sensory block Control Intervention1: To compare dexmedetomidine and magnesium sulphate as adJuvant with 0.5% bupivacaine in spinal anasthe

Sponsors

Department of anaesthesiology Jln Medical College ajmer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group between 18 and 65 years. 2.Body weight 30 to 80 kg. 3.Patients belonging ASA class-I & II. 4.Patients undergoing infraumbilical surgeries of duration 1-4 hours.

Exclusion criteria

Exclusion criteria: 1.Patients refusal. 2.Uncooperative patients. 3.Any known hypersensitivity or contraindication to Bupivacaine, Dexmedetomidine and Magnesium sulfate.

Design outcomes

Primary

MeasureTime frame
Duration of effective analgesia by visual analog scale (VAS).Timepoint: Duration of study around 1year—

Secondary

MeasureTime frame
Duration of sensory block. Duration of motor block Peri-operative sedation Score. Hemodynamic changes if any Adverse effects if anyTimepoint: Duration of study is around one year—

Countries

India

Contacts

Public ContactDr Kavita jain

Jln Medical College ajmer

drkavitajain15@gmail.com9414006151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026